Literature DB >> 21294751

A comparative study of marine salmonid alphavirus subtypes 1-6 using an experimental cohabitation challenge model.

D A Graham1, P Frost, K McLaughlin, H M Rowley, I Gabestad, A Gordon, M F McLoughlin.   

Abstract

A comparative challenge study of six marine isolates representing subtypes 1-6 of salmonid alphavirus (salmon pancreas disease virus, Genus Alphavirus, Family Togaviridae) was conducted in Atlantic salmon in a fresh water cohabitation trial. Histopathological lesions typical of pancreas disease were observed with all subtypes, and virus was re-isolated from serum of cohabitant fish in each case. Using a virus neutralization (VN) test neutralizing salmonid alphavirus (SAV) subtype 1 strain F93-125, VN antibodies were detected in all challenge groups, consistent with serological cross-reactivity between these subtypes. Using real-time RT-PCR, SAV RNA was detected in heart tissue from 2 to 3 weeks post-challenge (wpc) in all cohabitant groups excluding controls. The results obtained suggested differences in the dynamics of infection between strains of SAV and potentially between subtypes. Results for SAV subtypes 1 and 3 suggested essentially synchronous infection of cohabitant fish. These two study groups also had the highest virus load in heart tissue as measured by quantitative RT-PCR and also had the most extensive histopathological changes. In contrast, results for SAV subtypes 2 and 6 strains were consistent with asynchronous infection in the cohabitant fish and were characterized by slow spread, low virus loads and mild histopathological changes. The SAV subtype 4 and 5 strains occupied an intermediate position in this regard. Despite the use of concentration procedures, it was not possible to detect SAV RNA in water samples from selected study tanks. However, testing of faeces from the SAV subtypes 1, 3 and 6 challenge groups found positive signals in each beginning at 1-3 wpc and remaining detectable for a further 2-3 weeks. Parallel testing of mucus samples found these became positive at 2-3 wpc and remained positive for a further 1-3 weeks. These results demonstrate for the first time that shedding and transmission of virus may occur by both these routes and suggest that dispersal in these matrices should be included in any disease transmission models.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294751     DOI: 10.1111/j.1365-2761.2010.01234.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  20 in total

1.  Effect of vaccines against pancreas disease in farmed Atlantic salmon.

Authors:  Magnus Vikan Røsaeg; Ragnar Thorarinsson; Arnfinn Aunsmo
Journal:  J Fish Dis       Date:  2021-08-17       Impact factor: 2.580

Review 2.  The contribution of molecular epidemiology to the understanding and control of viral diseases of salmonid aquaculture.

Authors:  Michael Snow
Journal:  Vet Res       Date:  2011-04-05       Impact factor: 3.683

3.  Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system.

Authors:  Mia C Hikke; Marjan Verest; Just M Vlak; Gorben P Pijlman
Journal:  Microb Biotechnol       Date:  2014-01-14       Impact factor: 5.813

4.  Experimental Piscine orthoreovirus infection mediates protection against pancreas disease in Atlantic salmon (Salmo salar).

Authors:  Morten Lund; Magnus Vikan Røsæg; Aleksei Krasnov; Gerrit Timmerhaus; Ingvild Berg Nyman; Vidar Aspehaug; Espen Rimstad; Maria Krudtaa Dahle
Journal:  Vet Res       Date:  2016-10-21       Impact factor: 3.683

5.  Risk map and spatial determinants of pancreas disease in the marine phase of Norwegian Atlantic salmon farming sites.

Authors:  Saraya Tavornpanich; Mathilde Paul; Hildegunn Viljugrein; David Abrial; Daniel Jimenez; Edgar Brun
Journal:  BMC Vet Res       Date:  2012-09-24       Impact factor: 2.741

6.  Gene expression studies of host response to Salmonid alphavirus subtype 3 experimental infections in Atlantic salmon.

Authors:  Cheng Xu; Tz-Chun Guo; Stephen Mutoloki; Oyvind Haugland; Oystein Evensen
Journal:  Vet Res       Date:  2012-11-01       Impact factor: 3.683

7.  Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen.

Authors:  Hanna L Thim; Stéphane Villoing; Marian McLoughlin; Karen Elina Christie; Søren Grove; Petter Frost; Jorunn B Jørgensen
Journal:  Vaccines (Basel)       Date:  2014-03-25

8.  The serum proteome of Atlantic salmon, Salmo salar, during pancreas disease (PD) following infection with salmonid alphavirus subtype 3 (SAV3).

Authors:  M Braceland; R Bickerdike; J Tinsley; D Cockerill; M F Mcloughlin; D A Graham; R J Burchmore; W Weir; C Wallace; P D Eckersall
Journal:  J Proteomics       Date:  2013-10-18       Impact factor: 4.044

9.  Atlantic salmon (Salmo salar L.) post-smolts challenged two or nine weeks after seawater-transfer show differences in their susceptibility to salmonid alphavirus subtype 3 (SAV3).

Authors:  J Jarungsriapisit; L J Moore; G L Taranger; T O Nilsen; H C Morton; I U Fiksdal; S Stefansson; P G Fjelldal; Ø Evensen; S Patel
Journal:  Virol J       Date:  2016-04-11       Impact factor: 4.099

10.  Pathogenesis of experimental salmonid alphavirus infection in vivo: an ultrastructural insight.

Authors:  Tharangani K Herath; Hugh W Ferguson; Manfred W Weidmann; James E Bron; Kimberly D Thompson; Alexandra Adams; Katherine F Muir; Randolph H Richards
Journal:  Vet Res       Date:  2016-01-08       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.